[FairOpinion]

Very interesting.

I wish they said more about how do they think these eye drops actually work. Macular degeneration is the degeneration of the retina -- do these drops reverse it or halt it?

[nmh]

Did I miss it? What's the name of this drug?

[Quix]

THANKS TONS.

I must get this to my dad.

Blessings,

[NEPA]

Thanks for the information.

My mother suffers from macular degeneration and it has made life very frustrasting for her. She has always been a strong women (raised 6 kids pretty much alone) and it isn't easy for her to actually need help.

I'm going to bring this info to her next appointment.

[null and void]

Thanks.

Forwarded to my dad.

[Peace4EarthNow]

Bump up & THANK YOU for posting this!

My mom has MD, and none of the conventional treatments work for her.

I'll forward this to her, so she can ask her doctor to hopefully get this for her (if that's possible, since it's "experimental"?).

Worth a shot, anyway!

Thanks again...

[FairOpinion]

I found more info and I thought you would be interested.

Note that this article mentions the name of the drug: "Echothiophate iodide", they say that this drug has been used to treat glaucoma, the dosage for use against macular degenaration is much lower, than the dose used for glaucoma and that this medication is no longer manufactured in the US.

I did a search -- found that it is available in Europe, and that it can possibly be gotten via ophtalmologists in the US. This article also mentions the drug can cause cataracts ( in the dose used for glaucoma).

I think one should find out the dose used by Dr. Nolan (mentioned in the original posted article).

Anyway, here is the link the this second article (with a phone no. ophtalmologists can call on how to get it):

Echothiophate iodide shortage leaves US specialists struggling to find alternative for acute cases (march 2003)

http://www.escrs.org/eurotimes/March2003/echo.asp

Mr Petkus said the company has informed ophthalmologists about the availability of the drug through the IND process. The AAO received a statement from the company in early January and it is now posted on the AAO website www.aao.org.
“I didn’t see the statement until recently, while the shortage has been going on for about a year,” Dr Bizer said.

Mr Petkus estimates that the facility in Gosport will have FDA approval within the next 30 to 60 days from the time of writing. Then, the company will begin marketing the drug in the US again.

“It will be available to ophthalmologists without going through the IND process,” he said.
There is no shortage of the drug in Europe. To obtain an information pack with directions on how to get echothiophate iodide through an IND process, US ophthalmologists can call 1 800 666 7248 between 8 a.m. and 8 p.m. EST.

[dennisw]

bttttttttttttt

[null and void]

Bump - for all to see...